Trial Profile
Avastin in Combination With Radiation and Temozolomide Followed by Avastin, Temozolomide, and Topotecan for Glioblastoma Multiformes and Gliosarcomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary) ; Topotecan (Primary)
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 29 Mar 2022 Status changed from active, no longer recruiting to completed.
- 04 Feb 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 24 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.